Italia markets open in 5 hours 5 minutes

AbbVie Inc. (ABBV)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
165,40+1,68 (+1,03%)
Alla chiusura: 04:03PM EST
165,60 +0,20 (+0,12%)
Dopo ore: 07:35PM EST
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente163,72
Aperto163,69
Denaro164,49 x 800
Lettera165,98 x 1000
Min-Max giorno163,26 - 165,53
Intervallo di 52 settimane122,10 - 175,91
Volume4.421.020
Media Volume5.699.314
Capitalizzazione292,507B
Beta (5 anni mensile)0,67
Rapporto PE (ttm)22,05
EPS (ttm)7,50
Prossima data utili31 gen 2023 - 06 feb 2023
Rendimento e dividendo (forward)5,92 (3,58%)
Data ex dividendo12 gen 2023
Stima target 1A159,83
  • GlobeNewswire

    Sosei Heptares and AbbVie Enter New Multi-target Collaboration to Discover, Develop and Commercialize Novel Medicines Targeting Neurological Diseases

    New strategic collaboration leverages Sosei Heptares’ StaR® technology and SBDD platform and AbbVie’s extensive neuroscience expertise Second collaboration with AbbVie follows 2020 agreement focused on inflammatory and autoimmune diseasesSosei Heptares eligible to receive up to $80 million in upfront and near-term milestone payments and has potential to receive further downstream payments totalling up to US$1.2 billion, plus tiered royalties TOKYO, Japan and CAMBRIDGE, United Kingdom, Aug. 02, 2

  • GlobeNewswire

    Sirona Biochem Announces Exclusive Global Licensing Agreement with Allergan Aesthetics

    Licenses Revolutionary Skin Care Compound TFC-1067VANCOUVER, British Columbia, June 13, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) is pleased to announce it has entered into a global exclusive licensing agreement with Allergan Aesthetics, an AbbVie company (NYSE: ABBV), pursuant to which Allergan Aesthetics will develop and commercialize topical skin care treatments based on active ingredients derived from certain of Sirona’s patents for TFC-106

  • FX Empire

    Best Dividend Stocks to Buy Now for May 2022

    Markets have continued to be volatile for a while as inflation rages. In the past, dividend paying stocks have proven to be good hedges for these kinds of environments.